Patents by Inventor Shuli Zhang

Shuli Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12258009
    Abstract: A cruise control method and system, and a vehicle, the method being applied to a first vehicle. When the first vehicle is driving in a first lane, before the first vehicle enters from the first lane into a preset recognition region to thereby complete vehicle identity recognition in the preset recognition region, the cut-in probability of a second vehicle cutting into the first lane can be predicted according to a movement parameter of the second vehicle that is in an adjacent second lane, and it is determined, according to the cut-in probability and the stopping time of the first vehicle, whether to brake to stop the first vehicle; therefore, during the process of controlling the first vehicle to pass through the preset recognition region, the driver is not required to temporarily take over control of the first vehicle.
    Type: Grant
    Filed: April 19, 2021
    Date of Patent: March 25, 2025
    Assignee: GREAT WALL MOTOR COMPANY LIMITED
    Inventors: Jinchuan Li, Hejia Wei, Shuli Li, Longbao Zhen, Pu Li, Shasha Gao, Fengyue Zhang, Hongning Zhang, Hong Dong
  • Patent number: 12252542
    Abstract: An antibody may be capable of specifically binding CD137 or an antigen binding fragment thereof, wherein the light chain variable region and the heavy chain variable region have one or more mutations. The antibody or antigen binding fragment thereof may be used in preparing a drug. The antibody or an antigen binding fragment thereof may specifically bind CD137, and may include a light chain variable region VL and a heavy chain variable region VH, wherein compared to a sequence as shown in SEQ ID NO: 103, the VL comprises one or more VL amino acid mutations, and the VL amino acid mutation occurs at one or more positions: V3, A10, K44, D71, and/or V77.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: March 18, 2025
    Assignee: Shihuida Pharmaceutical Group (Jilin) Co., Ltd.
    Inventors: Xin Zhang, Jianjian Peng, Kai Fu, Hui Ma, Xiaolong Pan, Shilong Fu, Shuli Ma, Jian Ding
  • Publication number: 20220229893
    Abstract: A service request is received by a terminal device. First biometric authentication information of a user associated with the service request is collected. The first biometric authentication information is compated with preset biometric authentication information. When the comparison shows that the first biometric authentication information and the preset biometric authentication information are consistent, a pre-stored digital signature certificate private key is read. The service request is digitally signed according to the digital signature certificate private key. A biometric information verification message is generated and sent message to a server. The server is configured to read a pre-stored digital signature certificate public key corresponding to the digital signature certificate private key. Authentication result information is receiving from the server after the server verifies and signs the biometric information verification message according to the digital signature certificate public key.
    Type: Application
    Filed: April 4, 2022
    Publication date: July 21, 2022
    Applicant: Advanced New Technologies Co., Ltd.
    Inventors: Haojie Zhong, Xiangyu Zhao, Shuli Zhang
  • Patent number: 11294993
    Abstract: A service request is received by a terminal device. First biometric authentication information of a user associated with the service request is collected. The first biometric authentication information is compared with preset biometric authentication information. When the comparison shows that the first biometric authentication information and the preset biometric authentication information are consistent, a pre-stored digital signature certificate private key is read. The service request is digitally signed according to the digital signature certificate private key. A biometric information verification message is generated and sent message to a server. The server is configured to read a pre-stored digital signature certificate public key corresponding to the digital signature certificate private key. Authentication result information is receiving from the server after the server verifies and signs the biometric information verification message according to the digital signature certificate public key.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: April 5, 2022
    Assignee: Advanced New Technologies Co., Ltd.
    Inventors: Haojie Zhong, Xiangyu Zhao, Shuli Zhang
  • Publication number: 20180181739
    Abstract: A service request is received by a terminal device. First biometric authentication information of a user associated with the service request is collected. The first biometric authentication information is compated with preset biometric authentication information. When the comparison shows that the first biometric authentication information and the preset biometric authentication information are consistent, a pre-stored digital signature certificate private key is read. The service request is digitally signed according to the digital signature certificate private key. A biometric information verification message is generated and sent message to a server. The server is configured to read a pre-stored digital signature certificate public key corresponding to the digital signature certificate private key. Authentication result information is receiving from the server after the server verifies and signs the biometric information verification message according to the digital signature certificate public key.
    Type: Application
    Filed: February 23, 2018
    Publication date: June 28, 2018
    Applicant: Alibaba Group Holding Limited
    Inventors: Haojie Zhong, Xiangyu Zhao, Shuli Zhang
  • Publication number: 20070244052
    Abstract: The present invention provides methods for identifying agonists or antagonists of CD200R signaling. In addition, the present invention provides methods for treating patients suffering from CD200R-mediated medical conditions.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 18, 2007
    Inventors: Shuli Zhang, Joseph Phillips